Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainKRAB

ZNF430 ZNF573 ZNF100 ZNF234 ZNF257 ZNF267

6.25e-04358556PS50805
DomainKRAB

ZNF430 ZNF573 ZNF100 ZNF234 ZNF257 ZNF267

6.25e-04358556PF01352
DomainKRAB

ZNF430 ZNF573 ZNF100 ZNF234 ZNF257 ZNF267

7.32e-04369556SM00349
DomainKRAB

ZNF430 ZNF573 ZNF100 ZNF234 ZNF257 ZNF267

7.42e-04370556IPR001909
Domain-

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

7.87e-046795583.30.160.60
Domainzf-C2H2

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

8.99e-04693558PF00096
DomainZnf_C2H2/integrase_DNA-bd

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

9.07e-04694558IPR013087
DomainZINC_FINGER_C2H2_2

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

1.83e-03775558PS50157
DomainZINC_FINGER_C2H2_1

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

1.86e-03777558PS00028
DomainZnf_C2H2-like

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

2.17e-03796558IPR015880
DomainZnf_C2H2

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

2.33e-03805558IPR007087
DomainZnF_C2H2

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

2.38e-03808558SM00355
DomainKringle-like

MRC2 PLAT

3.99e-0332552IPR013806
Pubmed

Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.

LRP1 PLAT

2.46e-0625521502153
Pubmed

The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors.

LRP1 PLAT

2.46e-06255218321860
Pubmed

Recombinant Tissue Plasminogen Activator (r-tPA) Induces In-Vitro Human Neutrophil Migration via Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1).

LRP1 PLAT

2.46e-06255232977685
Pubmed

Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

LRP1 PLAT

2.46e-06255210632583
Pubmed

Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1.

LRP1 PLAT

2.46e-06255226237273
Pubmed

Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.

NF1 TBC1D23 EP300

3.00e-061855333323119
Pubmed

Tissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein kinase (MAPK) pathway.

LRP1 PLAT

7.36e-06355225670857
Pubmed

Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein.

LRP1 PLAT

7.36e-06355219608750
Pubmed

Tissue-type plasminogen activator regulates macrophage activation and innate immunity.

LRP1 PLAT

7.36e-06355228684538
Pubmed

Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.

LRP1 PLAT

7.36e-06355217170123
Pubmed

Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression.

LRP1 PLAT

7.36e-06355216303771
Pubmed

LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and myelin-associated glycoprotein.

LRP1 PLAT

7.36e-06355224129569
Pubmed

Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.

LRP1 PLAT

7.36e-06355219672275
Pubmed

Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.

LRP1 PLAT

1.47e-05455218037995
Pubmed

Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

LRP1 PLAT

1.47e-05455214617754
Pubmed

CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.

NF1 RNF213 FAR1 EP300

2.29e-0510455431240132
Pubmed

Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain.

LRP1 PLAT

2.45e-05555218628488
Pubmed

TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.

U2SURP MIDEAS EP300 ZMYM4 RAVER1

2.60e-0522055535785414
Pubmed

Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration.

LRP1 PLAT

3.67e-05655216601674
Pubmed

The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.

LRP1 PLAT

3.67e-05655219147818
Pubmed

Growth-dependent repression of human adenine nucleotide translocator-2 (ANT2) transcription: evidence for the participation of Smad and Sp family proteins in the NF1-dependent repressor complex.

NF1 EP300

6.83e-05855218215124
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

SLC25A42 ATP11B ABCC8 LRP1 RNF213 FGF13 ARHGEF4 EP300 ZMYM4 RAVER1

1.01e-041489551028611215
Pubmed

Genetic analysis of genes involved in amyloid-β degradation and clearance in Alzheimer's disease.

LRP1 PLAT

1.60e-041255222027013
Pubmed

The ins and outs of HIV-1 Tat.

LRP1 EP300

1.60e-041255221951552
Pubmed

Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.

CHL1 NF1

1.60e-041255222789544
Pubmed

Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.

ZNF430 ZNF100 ZNF257 ZNF267

1.97e-0418155437372979
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

WDR75 RNF213 MRTO4 MIDEAS DDX10

2.05e-0434155532971831
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

FAM120B NAMPT NF1 WDR75 U2SURP MRTO4 FAR1 MIDEAS DDX10

2.52e-04135355929467282
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

MRC2 LRP1 RNF213 PLAT

3.72e-0421455422199357
Pubmed

Lipoprotein receptor loss in forebrain radial glia results in neurological deficits and severe seizures.

LRP1 PLAT

4.13e-041955232579270
Pubmed

Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity.

RNF213 MRTO4 CD99L2

4.82e-049655334599178
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

NF1 WDR75 IL17RD PPP2R3C EP300 RAVER1

5.03e-0463855631182584
Pubmed

Isolation of cDNA clones for 42 different Krüppel-related zinc finger proteins expressed in the human monoblast cell line U-937.

ZNF234 ZNF267

5.06e-04215527865130
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

ZNF573 NF1 PPP3CB LRP1 ZMYM4

5.31e-0442055528065597
Pubmed

Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

WDR75 SLC19A3 LIMS4 RFX8 LIMS3

6.69e-0444255515815621
Pubmed

A MicroRNA Profile in Fmr1 Knockout Mice Reveals MicroRNA Expression Alterations with Possible Roles in Fragile X Syndrome.

CHL1 ASIC1

7.20e-042555224906954
Pubmed

Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.

RNF213 EP300 ZMYM4

8.36e-0411655321282530
Pubmed

BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.

MRC2 TBC1D23 FAR1 UVRAG

1.08e-0328555434369648
Pubmed

Mutation of LRP1 in cardiac neural crest cells causes congenital heart defects by perturbing outflow lengthening.

LRP1 SNAI3

1.11e-033155232546759
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

NF1 ATP11B WDR75 U2SURP

1.53e-0331355438270169
CytobandEnsembl 112 genes in cytogenetic band chr19p12

ZNF430 ZNF100 ZNF257

4.34e-04122553chr19p12
CytobandEnsembl 112 genes in cytogenetic band chr2q13

LIMS4 LIMS3

2.31e-0359552chr2q13
Cytoband2q13

LIMS4 LIMS3

3.05e-03685522q13
GeneFamilyLIM zinc finger domain containing|LIM domain containing

LIMS4 LIMS3

3.31e-0544321163
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF430 ZNF573 ZFAT ZNF100 ZNF234 ZNF257 ZNF267 SNAI3

2.51e-0471843828
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CHL1 ASIC1 ABCC8 LRP1 GABBR1

4.68e-06199555333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CHL1 ASIC1 ABCC8 LRP1 GABBR1

4.68e-06199555e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CHL1 ASIC1 ABCC8 LRP1 GABBR1

4.79e-06200555ad777683adeb2ce45ade570386235e311fa7ea2d
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CHL1 RNF213 PLAT HS3ST1 STC1

4.79e-062005550f6620a5baace704518d42fa2f3f90751240f7dd
ToppCellmild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2)

NF1 ASIC1 ZNF257 MRC2

3.73e-05152554f944743f40ff6ed3a7a096dd53e12d3526c67c4d
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SV2B ARHGEF4 IL17RD STC1

5.91e-05171554121e63ca281ad765d76c2afb3b4d441329b47f81
ToppCellCOPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class

NAMPT ABCC8 PLAT S1PR3

7.05e-05179554e816dd846a6918ec143b57a380c3a47ed073b66e
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MRC2 ABCC8 LRP1 S1PR3

7.36e-05181554a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MRC2 ABCC8 LRP1 S1PR3

7.36e-05181554526e858a848470b6d2d5248788004d9735ed3add
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC25A42 ST6GAL1 FGF13 HS3ST1

7.68e-051835542dde2fb48e7d31271c2f6b1dd74b2ab0b2cb520c
ToppCell367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CHL1 FAM120B MRC2 SLC19A3

8.01e-05185554b57dae20c21f984edd2acee4344d86f033108ebf
ToppCell367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CHL1 FAM120B MRC2 SLC19A3

8.01e-05185554d3b054d203e575c1bb5455aa7a2e551a0957a760
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ST6GAL1 HS3ST1 UVRAG PARP15

8.35e-05187554b5cb8760fa667c237902d50a78dea4cb1babd607
ToppCellCOVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

SV2B PLAT ST6GAL1 STC1

8.70e-05189554c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 MRC2 LRP1 S1PR3

8.70e-05189554e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLAT MRTO4 STC1 DDX10

8.88e-05190554a318d80dd5cc33d43048883b0e7844b5aa280aab
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MRC2 LRP1 HS3ST1 S1PR3

9.06e-051915541efb47743b6834b64cb0f61721ddbe875b1a66ca
ToppCellcontrol-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

KCNH2 PLAT HS3ST1 PARP15

9.06e-05191554afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5
ToppCellfacs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MRC2 LRP1 PLAT ZMYM4

9.06e-051915549214655dca96d766737c9f30b624d7fe7050342e
ToppCell10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue

CHL1 ST6GAL1 HS3ST1 UVRAG

9.25e-05192554fa99243ff028498c6a67d207a93e02c48e69cd42
ToppCellLPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 MRC2 LRP1 S1PR3

9.25e-051925544e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 MRC2 LRP1 S1PR3

9.25e-05192554f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAMPT PLAT HS3ST1 STC1

9.43e-05193554463274f394757fb2570ae885d58e1f9fa7e60c4a
ToppCellIPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class

NAMPT ABCC8 PLAT ST6GAL1

9.62e-05194554e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NAMPT ZNF267 LIMS4 HS3ST1

9.82e-0519555410f303cbe92777404e7cc93a4991250ce07e65e1
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAMPT ZNF267 LIMS4 EP300

1.00e-04196554c2bbb48c4aa979b03cb6f4ce9f351f492977c992
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAMPT ZNF267 LIMS4 EP300

1.00e-0419655464c2abc0087bf2ae547932377f3662e3be1cc63e
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAMPT ZNF267 LIMS4 EP300

1.00e-0419655401cea0bb0b938d0986fd2ddae06597b8af1768ee
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.04e-041985540a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAMPT SLC19A3 ZNF267 LIMS4

1.06e-041995545b6feacb0ca92c3fc6b327be978320426dcf6f68
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.06e-04199554ba586690f88fd051f449753bfe7603a2cb431782
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CHL1 ASIC1 ABCC8 LRP1

1.06e-0419955419a97e27a4758e794ce7246d295e112b47931a48
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.06e-0419955430d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CHL1 MRC2 LRP1 PLAT

1.06e-041995546139687a3a5025cb98da4dba0183f95fcae3dc61
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.06e-0419955438ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.06e-0419955406a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.06e-04199554c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.06e-04199554a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.06e-041995541a0add79f4e34078b3475eb11c85a4234bda197c
ToppCellwk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

MRC2 LRP1 PLAT S1PR3

1.06e-041995546bce8e65859a35cfea1c210f9c9765952d492ed2
ToppCellLPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.06e-04199554211c3a08f2d484ab7a3368006767289088f0d957
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-04200554ab4fda0cc95cb8f80ea9f28745013f3248def820
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-0420055444a68bacdb3d5bf563bd35952176995850933a81
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-0420055464ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-04200554b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-0420055450ca6550998e461ef26dd670351060bd940765a8
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type.

ASIC1 SV2B RFX8 STC1

1.08e-04200554332905a686356cd1e024d40679be98e9d8b1b5e8
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-04200554a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-04200554dc61016c61729f69649cfb21f6264e685ce83dea
ToppCellLPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_only / Treatment groups by lineage, cell group, cell type

IZUMO1 PLAT PPP2R3C HS3ST1

1.08e-04200554afbbfe0b8e66df36c244935182cb26feeb31a085
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-042005543bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

CHL1 MRC2 LRP1 S1PR3

1.08e-04200554bd8cf33502adea320e91ca2af14e1911d88ad374
Diseasesciatic neuropathy (biomarker_via_orthology)

NF1 ABCC8 LRP1 PLAT

2.64e-0599514DOID:11446 (biomarker_via_orthology)
DiseaseHeadache

LRP1 RNF213 DDX10

1.88e-0464513HP_0002315
DiseaseColorectal Carcinoma

CHL1 NAMPT NF1 ABCC8 LRP1 EP300 ZMYM4

1.95e-04702517C0009402
DiseaseDermatitis, Allergic Contact

NAMPT PLAT ST6GAL1

2.16e-0467513C0162820
DiseaseMoyamoya Disease

NF1 RNF213

3.92e-0417512C0026654
DiseaseDiabetes Mellitus, Non-Insulin-Dependent

ZNF257 ABCC8 INPPL1 ST6GAL1

5.81e-04221514C0011860
Diseasephosphatidylcholine measurement

ABCC8 AGPAT1 IZUMO1 UVRAG

1.47e-03284514EFO_0010226

Protein segments in the cluster

PeptideGeneStartEntry
SRVYKYCSKLSEVFE

EP300

1136

Q09472
RLTKLSKYVYFFEAC

ARHGEF4

391

Q9NR80
SKYVYFFEACRLLQK

ARHGEF4

396

Q9NR80
YCFVDKYKGTAFVTL

RAVER1

86

Q8IY67
EKSFYSFYVCTAVRK

PPP2R3C

211

Q969Q6
YNTIKDKFTRTCSSY

PARP15

506

Q460N3
VVSLCYKFLSYFRAS

FAR1

496

Q8WVX9
ALSKFIAVYFDYSCE

IL17RD

471

Q8NFM7
SDVKVYKEFCDFYAK

LIMS3

46

P0CW19
SDVKVYKEFCDFYAK

LIMS4

46

P0CW20
TTKYKFYLRACTSQG

CHL1

986

O00533
FYETEARKVFCEVYK

GABBR1

366

Q9UBS5
TTCYEFKKFLLYARQ

LRP1

1576

Q07954
SIKDKYVTALYFTFS

KCNH2

606

Q12809
DTKLRYCYKVFSSER

MRC2

676

Q9UBG0
AVSSYISYQQKKFCF

CD99L2

201

Q8TCZ2
TKTVAQCVEFYYTYK

MIDEAS

861

Q6PJG2
CKFKESVFENYYVTY

FGF13

141

Q92913
TFATYVARFQKEAYC

IZUMO1

121

Q8IYV9
SIVFFSSCKEVQYLY

DDX10

316

Q13206
TEYFTFKQECKIKYS

PPP3CB

166

P16298
FQDLKECYSSKRLFY

SLC19A3

266

Q9BZV2
LYSKKYIAFCISIFT

S1PR3

191

Q99500
SFRYKCLSSYTSVKE

FAM120B

241

Q96EK7
RKCVDTYKYLFIFSV

MRTO4

31

Q9UKD2
FYFNKTKGFYCLRDS

HS3ST1

246

O14792
CSTEKIYKEFYRSEV

UVRAG

71

Q9P2Y5
DTYFKNCTIESTIFY

SV2B

486

Q7L1I2
FIEFYSTCLEEYKKS

INPPL1

766

O15357
SKRKTDVCYYYQKFF

ST6GAL1

346

P15907
SKVYSYFECREKKTE

NAMPT

31

P43490
KRFSAKEAFRVLYYT

SLC25A42

66

Q86VD7
SEYSTVLAFCYRKAK

SPANXN1

46

Q5VSR9
RVFTCKYCDKEYTSL

SNAI3

181

Q3KNW1
YDICKSFLYSAAKFD

STC1

71

P52823
NASYYRKFFETKLCQ

U2SURP

611

O15042
AIVCYFIQKYFRVAS

ABCC8

1171

Q09428
AEDFKVVFTRYGKCY

ASIC1

181

P78348
RTLCIAYRKFTSKEY

ATP11B

626

Q9Y2G3
YFASFAKAYETVCKR

RNF213

2931

Q63HN8
KYTKLRDCYASVFKA

CTPS2

306

Q9NRF8
EECGKAFYRFSYLTK

ZNF100

376

Q8IYN0
FVYVCAVCRKKFVSS

ZFAT

456

Q9P243
YVFKAGKYSSEFCST

PLAT

191

P00750
YECKVCRKTFTFYRN

ZNF573

526

Q86YE8
FYLSVYFFKKKTTSR

WDR75

176

Q8IWA0
SSYQDFYCKKERRFT

AGPAT1

211

Q99943
DGICIKKSSFFYAQY

RFX8

91

Q6ZV50
CAKSYNFDQYRKVFT

ZNF267

156

Q14586
ITFYCKSRNIKYSTS

TBC1D23

111

Q9NUY8
TFCFKVYGATYLQKL

NF1

1286

P21359
KFYQCDEYKKSFTDV

ZNF234

146

Q14588
EECGKAFYRFSYLTK

ZNF430

376

Q9H8G1
RLYEFYLSKCSESVK

ZMYM4

1471

Q5VZL5
DKRFSCGNIYSFKYV

ZAR1L

306

A6NP61
QCDKYVKVFYKFSNS

ZNF257

146

Q9Y2Q1